Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Melanoma 16Carcinoma, Renal Cell 12Carcinoma, Non-Small-Cell Lung 9Neoplasm Metastasis 6Carcinoma, Transitional Cell 4Neoplasms 3Lung Neoplasms 3Clear-cell metastatic renal cell carcinoma 3Carcinoma, Hepatocellular 3Urogenital Neoplasms 2Urinary Bladder Neoplasms 2Urethral Neoplasms 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Penile Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Nasopharyngeal Carcinoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Kidney Neoplasms 2Glioblastoma 2Colorectal Neoplasms 2Carcinoma, Basal Cell 2Carcinoma 2Brain Neoplasms 2Vulvar Neoplasms 1

Interventions

Temozolomide 9Specimen Handling 6Radiotherapy 6Magnetic Resonance Spectroscopy 6Radiation 5trametinib 2dabrafenib 2Radiotherapy, Intensity-Modulated 2Bevacizumab 2vorasidenib 1vocimagene amiretrorepvec 1veliparib 1trastuzumab deruxtecan 1ribociclib 1Vorinostat 1Spinal Puncture 1Protons 1Proton Therapy 1Pluvicto 1Nivolumab 1Magnetic Resonance Imaging 1Leukapheresis 1Irinotecan 1Ipilimumab 1Flucytosine 1Everolimus 1DNA 1Carmustine 1Carboplatin 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Astrocytoma × Ipilimumab × 30 days × Clear all
NCT04145115 2026-05-29

A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden

National Cancer Institute (NCI)

Phase 2 Active not recruiting
37 enrolled
CNS

Astrocytoma, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡